Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-29

Clinical Trial Update: Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder [NA]

View source ↗

Summary

The clinical trial evaluating extended-release melatonin for REM sleep behavior disorder has been terminated. The study included participants with REM sleep beh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Extended-Release Melatonin (melatonin)

Snippet

Sponsor: Mayo Clinic | Conditions: Rapid Eye Movement Sleep Behavior Disorder, Parkinson Disease | NA | Status: TERMINATED